The vision and scope of the prophylactic dressing standard initiative of the European Pressure Ulcer Advisory Panel and National Pressure Injury Advisory Panel
Sign Up to like & getrecommendations! Published in 2022 at "International Wound Journal"
DOI: 10.1111/iwj.13859
Abstract: National and international standards exist to enable testing of the properties and performance of dressings used upon wounded skin and soft tissues. However, these same dressings can and are often used upon intact skin to… read more here.
Keywords: advisory panel; pressure ulcer; group; pressure ... See more keywords
Bid from the International Surgical Wound Complications Advisory Panel.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of wound care"
DOI: 10.12968/jowc.2022.31.sup3.s11
Abstract: The International Surgical Wound Complications Advisory Panel sets out its bid for the WUWHS 2026 Congress to be held in Perth, Western Australia. read more here.
Keywords: complications advisory; advisory panel; wound complications; international surgical ... See more keywords
Successful treatment with omalizumab for cold urticaria in a patient with chronic hepatitis C virus infection
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2022.4324
Abstract: 4. Nobukuni K, Hayakawa N, Namba R, et al. The influence of longterm treatment with povidone-iodine on thyroid function. Dermatology 1997; 195: 69-72. 5. Soldin OP. Urinary iodine percentile ranges in the United States. Clin… read more here.
Keywords: advisory panel; pressure ulcer; dermatology; ulcer advisory ... See more keywords
Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
Sign Up to like & getrecommendations! Published in 2023 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s388392
Abstract: Purpose Treatment-resistant depression (TRD) is associated with profound morbidity for patients, placing a significant burden on those affected, the health service and wider society. Despite this, TRD remains chronically underserved in terms of viable treatment… read more here.
Keywords: advisory panel; esketamine nasal; treatment; nasal spray ... See more keywords
Reasons for Discontinuation of Insulin Therapy—Results from the International Diabetes Management Practices Study (IDMPS)
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1026-p
Abstract: Adherence to insulin therapy is often suboptimal. Understanding patients’ perspectives on drug adherence is essential for identification of barriers to therapy. The IDMPS is a global observational survey on the management of people with type… read more here.
Keywords: advisory panel; speaker9s bureau; self; panel self ... See more keywords
Initiating Basal Insulin Supported Oral Therapy (BOT) with Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control in Patients (Pts) with Type 2 Diabetes (T2DM) without Increasing Hypoglycemia Risk
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1027-p
Abstract: Toujeo-1, a prospective observational study, investigates the effects of initiating BOT with Gla-300 in insulin-naive pts with T2DM in Germany (n=1,680) and Switzerland, insufficiently controlled (A1c 7.5-10%) on oral antidiabetic drugs (OADs) in daily clinical… read more here.
Keywords: insulin; advisory panel; gmbh; self ... See more keywords
Impact of Background Antihyperglycemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with T2DM from the BRIGHT Randomized Study
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1029-p
Abstract: BRIGHT (NCT02738151), the first head-to-head trial of Gla-300 and IDeg-100 in T2DM, is a multicenter, open-label, randomized, parallel-group, 24-week actively controlled study, conducted in insulin-naive participants uncontrolled on current antihyperglycemic drugs. Participants (mean baseline HbA… read more here.
Keywords: advisory panel; self; panel self; self sanofi ... See more keywords
Triple vs. Dual Therapy with Low-Dose Dapagliflozin plus Saxagliptin vs. Each Monocomponent Added to Metformin in Uncontrolled Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1149-p
Abstract: Triple therapy with dapagliflozin (DAPA) 10 mg/d + saxagliptin (SAXA) 5 mg/d added to metformin (MET) has greater efficacy than dual therapy in type 2 diabetes (T2D) inadequately controlled by MET alone. We tested triple… read more here.
Keywords: advisory panel; self; therapy; panel self ... See more keywords
More Subjects Achieved Composite Reductions of =1% HbA1c, =5% Body Weight, and =5 mmHg SBP with Semaglutide vs. Comparators (SUSTAIN 1-5, 7)
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-129-or
Abstract: Semaglutide is a new GLP-1 analog for the once-weekly treatment of type 2 diabetes (T2D). Across the SUSTAIN clinical trial program, subjects with T2D achieved significantly greater reductions in three cardiovascular (CV) risk factors with… read more here.
Keywords: advisory panel; research support; support self; self ... See more keywords
Potential Autocrine Effects of Type 2 Diabetes–Related Myokines on Human Skeletal Muscle
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1902-p
Abstract: Myokines are factors secreted by muscle cells that have been suggested to exert an array of autocrine, paracrine and/or endocrine actions. Secretion of a number of these myokines has been reported to be altered in… read more here.
Keywords: advisory panel; pharmaceuticals inc; self; panel self ... See more keywords
Individual and Combined Glucose-Lowering Effects of Glucagon Receptor Antagonism and Sodium-Glucose Cotransporter 2 Inhibition
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1942-p
Abstract: Studies suggest that sodium-glucose cotransporter 2 inhibitors (SGLT2i) induce hyperglucagonemia, which might counteract its glucose-lowering ability in type 2 diabetes. In a randomized, placebo-controlled, double-dummy, double-blinded, cross-over study, 12 middle-aged patients with type 2 diabetes… read more here.
Keywords: advisory panel; bureau self; speaker9s bureau; self ... See more keywords